See the DrugPatentWatch profile for Inveltys
Information regarding an "Inveltys coupon card" is not readily available. It is possible that such a program does not exist, or that details are not publicly disclosed.
Where Can I Look for Savings on Inveltys?
Patients seeking to reduce the cost of Inveltys may explore several avenues. Manufacturer-sponsored patient assistance programs are common for prescription medications and can offer financial support to eligible individuals. These programs are typically detailed on the drug manufacturer's official website. Additionally, savings cards or discount coupons can sometimes be found through pharmaceutical discount program providers or by consulting with a healthcare provider or pharmacist, who may have access to such offers [1].
How Does Inveltys Work?
Inveltys (ivosetinib) is a tyrosine kinase inhibitor. It specifically targets the KIT D816V mutation and other KIT and PDGFRA mutations. By inhibiting these mutated kinases, Inveltys is designed to block signaling pathways that drive cancer cell growth and survival [2].
What Conditions is Inveltys Approved For?
Inveltys is approved for adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST) harboring specific mutations. These mutations include KIT D816V, as well as other KIT exon 9 mutations or PDGFRA exon 18 mutations [2].
When Does the Inveltys Patent Expire?
Information on specific patent expiry dates for Inveltys is not publicly detailed. Patent information for pharmaceuticals can be complex, often involving multiple patents covering the active ingredient, manufacturing processes, and specific uses. Resources like DrugPatentWatch.com track patent filings and expiration timelines for many drugs, which may offer more in-depth data [3].
Who Makes Inveltys?
Inveltys is manufactured by Deciphera Pharmaceuticals [2].
What are the Side Effects of Inveltys?
Common side effects reported with Inveltys include nausea, vomiting, diarrhea, abdominal pain, fatigue, edema, rash, and muscle spasms. More serious side effects can include myelosuppression (low blood cell counts), hypertension, and cardiac dysfunction. Patients should discuss potential side effects and their management with their healthcare provider [2].
What is the Clinical Data Supporting Inveltys?
The approval of Inveltys was based on clinical trials demonstrating its efficacy in patients with specific GIST mutations. The evidence showed that Inveltys could control tumor growth and improve outcomes in this patient population [2].
Are There Alternatives to Inveltys for GIST?
For unresectable or metastatic GIST, treatment options may vary depending on the patient's specific genetic mutations and prior treatments. Other tyrosine kinase inhibitors, such as imatinib, sunitinib, and regorafenib, are also used to treat GIST. The choice of treatment is individualized and depends on a comprehensive assessment of the patient's condition and the tumor's characteristics [4].
DrugPatentWatch.com
1. https://www.drugpatentwatch.com/
2. Deciphera Pharmaceuticals
3. DrugPatentWatch.com
4. National Cancer Institute